Delivery Order SPE2DB20D1100-SPE2DB24FB1R0
Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,399.20 to provide RENFLEXIS 100 MG VIALS. This delivery order was issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and runs through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RENFLEXIS 100 MG VIALS. The delivery order, valued at $11,060.84, has a completion date of February 27, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency (DLA) awarded a $32,806.04 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of RENFLEXIS 100 MG VIALS. This delivery order contract has a period of performance through March 20, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,909.12 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RENFLEXIS 100 MG VIALS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $6,529.60 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564712042 RENFLEXIS 100 MG VIALS. This contract has an ultimate completion date of May 28, 2024 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,461.48 to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the provision of RENFLEXIS 100 MG VIALS, a pharmaceutical product, with a completion date of February 21, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, with a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $13,349.84 to AmerisourceBergen Drug Corp, Corporate Office Division, for the supply of 4565602174 RENFLEXIS 100 MG VIALS. This contract is a firm-fixed-price agreement with an ultimate completion date of August 28, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medical commodities to support military treatment facilities and other federal healthcare programs. The contract...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation, for the supply of RENFLEXIS 100 MG VIALS. This $8,676.47 firm fixed-price contract has an ultimate completion date of April 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 mg vials of the pharmaceutical product RENFLEXIS. The contract has a completion date of February 16, 2024 and a potential value of $4,273.18. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This contract is part of a larger indefinite delivery contract (IDC) awarded solely...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $6,688.73 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 100 mg vials of the pharmaceutical product RENFLEXIS. The delivery order was issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025. This...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB1R0Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $17,578.49 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RENFLEXIS 100 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has an ultimate completion date of April 9, 2024 and does not include any set-aside designations.
Generated 7/8/24, 9:20 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.6k | 4/8/24 |